Cours Benitec Biopharma Limited Deutsche Boerse AG
Actions
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 145 M 97,96 M 89,49 M 86,9 M |
---|---|---|---|---|---|
Résultat net 2024 * | -34 M -22,96 M -20,98 M -20,37 M | Résultat net 2025 * | -42 M -28,36 M -25,91 M -25,16 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 0 | Trésorerie nette 2025 * | - 0 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-2,06
x | PER 2025 * |
-5,55
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 90,72% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/10/16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/15 |
Megan Boston
CMP | Compliance Officer | 52 | 01/08/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01/04/13 |
Edward Smith
BRD | Director/Board Member | 53 | 14/04/20 |
Peter Francis
BRD | Director/Board Member | 68 | 01/02/06 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 47,96 Md | |
+45,94% | 41,47 Md | |
+0,69% | 42,45 Md | |
+30,52% | 31,6 Md | |
+22,30% | 28,63 Md | |
-6,35% | 28,03 Md | |
+49,25% | 14,56 Md | |
+49,18% | 14,14 Md | |
+3,45% | 12,58 Md |